Last $0.73 USD
Change Today +0.05 / 7.35%
Volume 28.6K
OXYS On Other Exchanges
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

oxysure systems inc (OXYS) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/17/13 - $0.90
52 Week Low
02/6/14 - $0.51
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for OXYSURE SYSTEMS INC (OXYS)

Related News

No related news articles were found.

oxysure systems inc (OXYS) Related Businessweek News

No Related Businessweek News Found

oxysure systems inc (OXYS) Details

OxySure Systems, Inc., a medical technology company, engages in the design, manufacture, and distribution of respiratory and emergency medical solutions. It provides OxySure Model 615, a portable emergency oxygen device. The company also offers complimentary products and solutions, including display wall boxes, oxygen wall signage, resuscitation bags, pulse oximeters, and automated external defibrillators, as well as thermal bags and replacement cartridges for its OxySure Model 615. Its products enhance the access to emergency oxygen that affects the survival, recovery, and safety of individuals in various areas of need. The company sells its products to institutional customers through distributors, sub-distributors, and sales agents in the United States and internationally. OxySure Systems, Inc. was founded in 2004 and is based in Frisco, Texas.

oxysure systems inc (OXYS) Top Compensated Officers

Founder, Chairman, Chief Executive Officer, P...
Total Annual Compensation: $90.0K
Compensation as of Fiscal Year 2012.

oxysure systems inc (OXYS) Key Developments

OxySure Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2013

OxySure Systems, Inc. reported earnings results for the full year ended December 31, 2013. For the fiscal year ended December 31, 2013, revenues increased by 566% to $1,800,327 from $270,387 in the comparable period last year. The increase was primarily driven by a 787% surge in revenues in the United States. Net loss during fiscal year ended December 31, 2013 decreased to $712,452, or $0.03 diluted per share compared to $1,144,799 or $0.06 diluted per share for fiscal year ended December 31, 2013. Loss from operations was $488,298 against $1,138,188 a year ago. Net cash used in operating activities was $860,791 against $377,388 a year ago. Purchase of property and equipment was $12,105 against $32,876 a year ago. Purchase of intangible assets was $4,262 against $3,172 a year ago.

OxySure Systems, Inc., Q4 2013 Earnings Call, Apr 16, 2014

OxySure Systems, Inc., Q4 2013 Earnings Call, Apr 16, 2014

OxySure Systems, Inc. Announces CE Mark Approval for OxySure Model 615 Portable Emergency Oxygen Device

OxySure Systems, Inc. announced its OxySure Model 615 portable emergency oxygen device has received CE Mark approval, a critical step toward launching this unique product into the thirty countries belonging to the European Economic Area (EEA). The OxySure Model 615 enables lay persons, from bystanders to family members, to administer medical oxygen easily and quickly in any medical emergency, while waiting for paramedics or first responders to arrive on the scene.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OXYS:US $0.73 USD +0.05

OXYS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OXYS.
View Industry Companies

Industry Analysis


Industry Average

Valuation OXYS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.2x
Price/Book 13.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 9.8x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OXYSURE SYSTEMS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at